Navigation Links
TriReme Medical Announces $17 Million Series D Financing
Date:10/11/2010

PLEASANTON, Calif., Oct. 11 /PRNewswire/ -- TriReme Medical, a leading developer of innovative catheters and stents for the treatment of complex vascular disease, announced today the closing of a $17M Round D financing.  The financing was led by Bio*One Capital, a subsidiary of Singapore based EDB Investments ('EDBI') with strong support from current investors, Three Arch Partners and Adams Street Partners.  "We are delighted to have Bio*One join our group of sophisticated blue chip investors who share our vision of developing innovative catheter and stent technology for coronary and peripheral interventional procedures," said Eitan Konstantino, Ph.D., President and CEO of TriReme Medical, Inc.  "This investment will allow us to ramp up our commercial activities worldwide, continue to develop internal R&D programs and pursue key regulatory approvals for our products in large markets such as the US, Japan, and China."

Ms Chu Swee-Yeok, CEO EDBI and Bio*One Capital said, "We are impressed with the global vision of TriReme's management team and its ability to rapidly develop and gain regulatory approvals for its novel catheter technologies.  Its strategy of positioning itself in Singapore will allow the company to tap on the fast growing Asian markets and enhance its competitiveness and reach." Mark Wan, General Partner at Three Arch Partners added, "This investment will allow TriReme to maximize the value of its R&D portfolio by providing for expansion of regulatory approvals and the creation of a commercial infrastructure that will drive revenue growth in the coming years."

About TriReme Medical, Inc.

Based in Pleasanton, California, TriReme Medical, Inc. (TMI) is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease.  The Company's novel balloon and stent therapies are specifically designed for large, unmet clinical needs.

About EDBI and Bio*One Capital

EDBI (EDB Investments) is a leading investment firm headquartered in Singapore with worldwide presence.  EDBI invests globally in the innovative and dynamic sector of Biomedical Sciences through its subsidiary Bio*One Capital, as well as in other key industries such as Clean Technologies and Digital Media.  As a value-adding investor, EDBI works closely with its portfolio companies, leveraging its extensive networks and experience to help bridge and drive the companies' growth strategies for Asia.

For more information please visit www.edbi.com.

About Three Arch Partners

Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital.  Three Arch has helped create, build and fund more than 100 important new healthcare companies.  These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns.  The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.

About Adams Street Partners

Based in Menlo Park, California, Adams Street Partners is one of the largest managers of private equity investments in the world.  The firm provides private equity fund of funds and direct partnership capabilities to institutional clients.  Currently, Adams Street Partners manages over $20 billion in private equity assets for clients in Australia, Japan, North America, the U.K. and Europe.


'/>"/>
SOURCE TriReme Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. TriReme Medical, Inc. Receives FDA 510K Clearance for Glider(TM) PTA Balloon Catheter
2. TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System
3. Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS)
4. Varian Medical Systems Schedules Fourth Quarter FY2010 News Release and Conference Call
5. Cantel Medical Corp. to Hold Conference Call to Discuss Fourth Quarter and Fiscal 2010 Results
6. Concentric Medical Announces Commercial Launch of Trevo™ in Europe
7. CSA Medical Selected to Present at AdvaMed 2010: The MedTech Conference
8. Nonin Medical Announces Its Second-Generation Wrist-Worn Device for European Distribution: Delivering Reliability in the Widest Range of Patient Populations and Clinical Settings
9. Bayer and Onyx Announce Nexavar Data Presentations at 35th European Society for Medical Oncology Congress
10. DSM Biomedical to be Key Contributor at the Surfaces in Biomaterials Foundations 2010 BioInterface Symposium and Workshop
11. International Menopause Society Calls Upon Medical Community to Improve the Vaginal Health of Postmenopausal Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)...  Hologic, Inc. (Nasdaq: HOLX ) ... fiscal second quarter ended March 26, 2016.  GAAP ... 41.2%, and non-GAAP diluted EPS of $0.47 increased ... a reported basis, and 6.3% on a constant ... good quarter, highlighted by 14.6% growth in non-GAAP ...
(Date:4/27/2016)...   , ... le trimestre, soutenu par une croissance de +42% ... de +16% des ventes aux hôpitaux et cliniques  ... (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur de Cellvizio®, ... chiffre d,affaires pour le premier trimestre clos au ...
(Date:4/27/2016)... -- Elekta today announced that its leading-edge ... focal point of seven scientific presentations at ESTRO 35, ... & Oncology, taking place April 29 - May 3. ... and a high-field MRI scanner with sophisticated software that ... in real time. The MR-linac is designed to improve ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 2016 , ... World Patent Marketing , a vertically ... automotive invention that improves the storage features of a pick up truck. , ... Cooper, CEO and Creative Director of World Patent Marketing. "Over the next five ...
(Date:4/29/2016)... Arizona (PRWEB) , ... April 29, 2016 , ... ... Healing and Spiritual Awakening , announces the addition Onnit brand Alpha BRAIN and ... The addition of Onnit brain and mood optimization products to the store is ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... Philadelphia, PA (PRWEB) , ... April 29, 2016 ... ... Pennsylvania announced that student team BioCellection won the $30,000 Perlman Grand Prize of ... Impact Prize, the Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... Dr. ... cosmetic dental treatments to improve smiles. Cosmetic dentistry is a fast-growing field as more ... This offer allows patients to learn more about the options currently available to them ...
Breaking Medicine News(10 mins):